Conclusion
we believe the incidence of this opportunistic infection is increasing due to the higher incidence of the mentioned risk factors and the key solution was early detection since mucormycosis has broad manifestation and correct intervention to reduce mortality and morbidity.
Author contributions: GS, NAD, and MAS were involved in the interpretation and collecting of data and editing of the manuscript, MADO was involved in drafting the first version of the manuscript and editing, and GB was involved in collecting data and editing and submitting the manuscript. All authors reviewed the paper and approved the final version of the manuscript.

References:

1. Bhattacharyya, A., et al., Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review. Indian journal of pharmacology, 2021.53 (4): p. 317-327.
2. Petrikkos, G., et al., Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis, 2012. 54 Suppl 1 : p. S23-34.
3. White, P.L., et al., A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit. Clin Infect Dis, 2021. 73 (7): p. e1634-e1644.
4. SeyedAlinaghi, S., et al., The clinical outcomes of COVID-19 in HIV-positive patients: A systematic review of current evidence.Immunity, Inflammation and Disease, 2021. 9 (4): p. 1160-1185.
5. Uraguchi, K., et al., A case of rhinocerebral mucormycosis with brain abscess drained by endoscopic endonasal skull base surgery.Medical Mycology Case Reports, 2020. 30 : p. 22-25.
6. Therakathu, J., et al., Imaging features of rhinocerebral mucormycosis: A study of 43 patients. The Egyptian Journal of Radiology and Nuclear Medicine, 2018. 49 (2): p. 447-452.
7. Sharma, S., et al., Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol, 2021.135 (5): p. 442-447.
8. Roushdy, T. and E. Hamid, A case series of post COVID-19 mucormycosis—a neurological prospective. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2021. 57 (1): p. 100.
9. Hirabayashi, K.E., et al., Retrobulbar Injection of Amphotericin B for Orbital Mucormycosis. Ophthalmic Plast Reconstr Surg, 2017. 33 (4): p. e94-e97.